Explore Pain Management Therapeutics Market: Valued at $73.6

Significant usage of pain management drugs, especially prescriptive medications such as non-steroidal anti-inflammatory drugs (NSAIDs), is anticipated to propel the marketWilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global pain management therapeutics market was valued at US$ 73.6 Bn in 2021 and is projected to surpass US$ 98.0 Bn by 2031. Extensive research in personalized pain management for chronic pain in the past few years ha

Related Keywords

China , India , Delaware , United States , Japan , Canada , America , Asia Pacific , Nikhil Sawlani , Purdue Pharma , Depomed Inc , Merck Co , Transparency Market Research Inc , Route Of Administration , Teva Pharmaceutical Industries Ltd , Merck Co Inc , Endo International , Transparency Market Research , Johnson , Mallinckrodt Pharmaceuticals , Venus Remedies , Cq Biomed Inc , Pfizer Inc , Glaxosmithkline , Astrazeneca , Market Research , Business Strategy , Market Intelligence , Request Your Free Sample Copy Now , Middle East , Venus Remedies Limited , In Depth Competitive Analysis , Buy Now , Growth Drivers , Pain Management Therapeutics , Canada Toll Free , Pain Management , Chronic Pain , Market Development , Market Size , Glaxosmithkline Plc , North America ,